These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 21668398)

  • 1. Stem-cell transplantation in children and adults with sickle cell disease: an update.
    Khoury R; Abboud MR
    Expert Rev Hematol; 2011 Jun; 4(3):343-51. PubMed ID: 21668398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.
    Locatelli F; Pagliara D
    Pediatr Blood Cancer; 2012 Aug; 59(2):372-6. PubMed ID: 22544533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of unrelated placental blood cells in children with high-risk sickle cell disease.
    Adamkiewicz TV; Mehta PS; Boyer MW; Kedar A; Olson TA; Olson E; Chiang KY; Maurer D; Mogul MJ; Wingard JR; Yeager AM
    Bone Marrow Transplant; 2004 Sep; 34(5):405-11. PubMed ID: 15247929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Will developments in allogeneic transplantation influence treatment of adult patients with sickle cell disease?
    Chakrabarti S; Bareford D
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):23-31. PubMed ID: 14752776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxyurea treatment for sickle cell disease: impact on haematopoietic stem cell transplantation's outcome.
    Brachet C; Azzi N; Demulder A; Devalck C; Gourdin A; Gulbis B; Klein A; Le PQ; Loop M; Sariban E; Ferster A
    Bone Marrow Transplant; 2004 Apr; 33(8):799-803. PubMed ID: 14767501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic cellular gene therapy for hemoglobinopathies.
    Gaziev J; Lucarelli G
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell transplantation after reduced-intensity conditioning for sickle cell disease.
    Matthes-Martin S; Lawitschka A; Fritsch G; Lion T; Grimm B; Breuer S; Boztug H; Karlhuber S; Holter W; Peters C; Minkov M
    Eur J Haematol; 2013 Apr; 90(4):308-12. PubMed ID: 23369103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation for sickle cell disease: The changing landscape.
    Kassim AA; Sharma D
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):259-266. PubMed ID: 28641096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem cell transplantation from sibling and unrelated donors in pediatric patients with sickle cell disease-A single center experience.
    Kogel F; Hakimeh D; Sodani P; Lang P; Kühl JS; Hundsdoerfer P; Künkele A; Eggert A; Oevermann L; Schulte JH
    Pediatr Transplant; 2021 Mar; 25(2):e13892. PubMed ID: 33098344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.
    Al-Mousa H; Al-Shammari Z; Al-Ghonaium A; Al-Dhekri H; Al-Muhsen S; Al-Saud B; Arnaout R; Al-Seraihy A; Al-Jefri A; Al-Ahmari A; Ayas M; El-Solh H
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):818-23. PubMed ID: 20079864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research.
    Panepinto JA; Walters MC; Carreras J; Marsh J; Bredeson CN; Gale RP; Hale GA; Horan J; Hows JM; Klein JP; Pasquini R; Roberts I; Sullivan K; Eapen M; Ferster A;
    Br J Haematol; 2007 Jun; 137(5):479-85. PubMed ID: 17459050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.
    Aversa F; Reisner Y; Martelli MF
    Blood Cells Mol Dis; 2004; 33(3):294-302. PubMed ID: 15528148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease.
    van Besien K; Bartholomew A; Stock W; Peace D; Devine S; Sher D; Sosman J; Chen YH; Koshy M; Hoffman R
    Bone Marrow Transplant; 2000 Aug; 26(4):445-9. PubMed ID: 10982293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry.
    Gross TG; Filipovich AH; Conley ME; Pracher E; Schmiegelow K; Verdirame JD; Vowels M; Williams LL; Seemayer TA
    Bone Marrow Transplant; 1996 May; 17(5):741-4. PubMed ID: 8733691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sibling donor cord blood banking for children with sickle cell disease.
    Reed W; Walters M; Trachtenberg E; Smith R; Lubin BH
    Pediatr Pathol Mol Med; 2001; 20(2):167-74. PubMed ID: 12673840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
    Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
    Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of unrelated cord blood units for hematopoietic stem cell transplantation in children with sickle cell disease.
    Adamkiewicz TV; Boyer MW; Bray R; Haight A; Yeager AM
    J Pediatr Hematol Oncol; 2006 Jan; 28(1):29-32. PubMed ID: 16394889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation for sickle cell disease.
    Robinson TM; Fuchs EJ
    Curr Opin Hematol; 2016 Nov; 23(6):524-529. PubMed ID: 27496639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Availability of unrelated donors for hematopoietic stem cell transplantation for hemoglobinopathies.
    Krishnamurti L; Abel S; Maiers M; Flesch S
    Bone Marrow Transplant; 2003 Apr; 31(7):547-50. PubMed ID: 12692619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonmyeloablative approaches to the treatment of sickle hemoglobinopathies.
    Amado RG; Schiller GJ
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):82-9. PubMed ID: 10877059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.